The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients

por Mast, L., Peeters, M. Y. M., Söhne, M., Hackeng, C. M., Knibbe, C. A. J., van den Broek, M. P. H.
Publicado 2023

The hypercoagulable profile of patients with stent thrombosis

por Loeffen, R, Godschalk, T C, van Oerle, R, Spronk, H M H, Hackeng, C M, ten Berg, J M, ten Cate, H
Publicado 2015

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit

por Vlot, E.A., Van den Dool, E.J., Hackeng, C.M., Sohne, M., Noordzij, P.G., Van Dongen, E.P.A.
Publicado 2020

Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an incr...

por Breet, N. J., van Donkersgoed, H. E., van Werkum, J. W., Bouman, H. J., Kelder, J. C., Zijlstra, F., Hackeng, C. M., ten Berg, J. M.
Publicado 2011

Effect of gender difference on platelet reactivity

por Breet, N. J., Sluman, M. A., van Berkel, M. A. J. P. J., van Werkum, J. W., Bouman, H. J., Harmsze, A. M., Kelder, J. C., Zijlstra, F., Hackeng, C. M., ten Berg, J. M.
Publicado 2011